Table 3.
Reported patient populations that reduced oxygen concentration is used for: (Number of cycles/year)
| The entire IVF population N (%) | Poor responder patients N (%) | Patients with repeated implantation failures N (%) | Patients intended for blastocyst transfer N (%) | Not used at all N (%) | Total Cycles N | P-value | |
|---|---|---|---|---|---|---|---|
| USA & Canada | 30,100 (64.45) | 300 (0.64) | 300 (0.64) | 2,200 (4.71) | 13,800 (29.55) | 46,700 | <0.001 |
| South America | 1,900 (32.20) | 0 | 0 | 200 (3.39) | 3,800 (64.41) | 5,900 | |
| Europe | 28,300 (43.88) | 200 (0.31) | 0 | 3,200 (4.96) | 32,800 (50.85) | 64,500 | |
| Africa | 3,100 (34.83) | 0 | 0 | 3,000 (33.71) | 2,800 (31.46) | 8,900 | |
| Asia | 9,000 (33.83) | 0 | 500 (1.88) | 1,300 (4.89) | 15,800 (59.40) | 26,600 | |
| Australia | 8,100 (93.10) | 0 | 0 | 0 | 600 (6.90) | 8,700 |